hello world
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
Stocks in play: Microbix Biosystems Inc.
Is presenting results of a novel Quality Assessment Product for supporting patient diagnosis and tissue analysis relating to infection with the Herpes Simplex Virus at the European Meeting on Molecular Diagnostics taking place in Noordwijk, The Netherlands, October 9 to 11. Microbix Biosystems Inc. shares T.MBX are trading down $0.01 at $0.35.
